VISTAGEN_13GAPR42022

Company

Vistagen Therapeutics, Inc.

Filed

April 14, 2022

Accession Number

0000905718-22-000607

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →